44 results
424B3
ATXI
Avenue Therapeutics Inc
2 Feb 24
Prospectus supplement
12:00am
from bringing a lawsuit against our directors for breach of fiduciary duty. These provisions also may reduce the likelihood of derivative litigation
8-K
EX-10.2
ATXI
Avenue Therapeutics Inc
2 Nov 23
Avenue Therapeutics Announces Pricing of $5.0 Million Public Offering
4:10pm
3.1(hh), there is no pending, completed or, to the Company's knowledge, threatened, action (including any lawsuit, arbitration, or legal
424B4
i2zehrvwbg7zeebnzbj0
2 Nov 23
Prospectus supplement with pricing info
9:00am
424B3
2hxtfg2 x865
28 Jun 23
Prospectus supplement
4:56pm
424B3
ikjrx924rucr3 6oqlp
4 May 23
Prospectus supplement
4:30pm
424B4
7xp3 7izene2
11 Oct 22
Prospectus supplement with pricing info
8:27am